AN2 Therapeutics, Inc.

ANTX · Nasdaq · SIC 2834: Pharmaceutical Preparations
60
SEC Filings

Business Summary

. All brand names or trademarks appearing in this report are the property of their respective owners. Unless the context requires otherwise, references in this report to AN2, we, our, the Company or the Registrant refer to AN2 Therapeutics. Overview We are a clinical stage biopharmaceutical company focused on the discovery and development of novel small-molecule therapeutics derived from our boron chemistry platform. Our development pipeline spans hematologic diseases, infectious diseases, and o...

Next Earnings

Q2 FY2026 — expected 2026-08-12

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionANTXdiscussed_in_filing Cybersecurity
topic_mentionANTXdiscussed_in_filing Cybersecurity
topic_mentionANTXdiscussed_in_filing Healthcare & Bio
topic_mentionANTXdiscussed_in_filing Platform & Ecosystem
topic_mentionANTXdiscussed_in_filing Healthcare & Bio
topic_mentionANTXdiscussed_in_filing Platform & Ecosystem

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-172025-12-310001193125-26-110693EDGAR79K words
2025-03-252024-12-310000950170-25-044366EDGAR—
2024-03-292023-12-310000950170-24-038681EDGAR—
2023-03-292022-12-310000950170-23-010627EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-122025-09-300001193125-25-277673EDGAR60K words
2025-08-122025-06-300000950170-25-107301EDGAR—
2025-05-132025-03-310000950170-25-070358EDGAR—
2024-11-132024-09-300000950170-24-126282EDGAR—
2024-08-132024-06-300000950170-24-096243EDGAR—
2024-05-142024-03-310000950170-24-059556EDGAR—
2023-11-092023-09-300000950170-23-062081EDGAR—
2023-08-102023-06-300000950170-23-041378EDGAR—
2023-05-112023-03-310000950170-23-021291EDGAR—
2022-11-092022-09-300000950170-22-023901EDGAR—
2022-08-112022-06-300000950170-22-016900EDGAR—
2022-05-102022-03-310000950170-22-008999EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-200001193125-26-117765EDGAR1K words
2026-03-170001193125-26-110681EDGAR—
2026-03-100001193125-26-099169EDGAR—
2026-01-290001193125-26-029540EDGAR—
2025-11-120001193125-25-277662EDGAR—
2025-08-120000950170-25-107278EDGAR—
2025-06-200001193125-25-143187EDGAR—
2025-06-110001193125-25-138796EDGAR—
2025-05-270001193125-25-127595EDGAR—
2025-05-130000950170-25-070305EDGAR—

60 total filings indexed. 34 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001880438
TickerANTX
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 8680f122f68f93f616374a4456a37313ae755f558e47eac1e22be20dca1029ae
parent: c83f03dddc3894ff6f7f46a98a40f8740051feaf51dfdcd3f3de3feb2c1f71b3
content hash: 4946b4bf0b256b56b9412e31b52e636ce6937d8f13e9193ac40952e7122653a2
signed: 2026-04-13T04:43:39.956Z
sources: 16 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf